Paracetamol Profilaksis Pascavaksinasi Aman untuk Diberikan

Oleh :

Rainey Ahmad Fajri Putranta

Penggunaan paracetamol profilaksis pascavaksinasi merupakan tindakan yang kontroversial akibat adanya pengurangan imunogenisitas. Walau demikian, studi menemukan bahwa antipiretik profilaksis pascavaksinasi, seperti paracetamol dan ibuprofen, aman untuk diberikan dan tidak berpengaruh terhadap efektivitas vaksin.

Di Amerika Serikat, demam merupakan kejadian ikutan pascaimunisasi tersering, terjadi pada 1-10% anak di Amerika Serikat.[1] Walaupun begitu, insidensi terjadinya tergantung pada jenis vaksin yang diberikan. Pada Petunjuk Teknis Kampanye dan Introduksi Measles dan Rubella, demam ringan (suhu di bawah 39,4° C) terjadi pada 1 per 10 anak dan demam >39,4° C terjadi pada 1 per 20 anak.[2]

Kontroversi Pemberian Antipiretik Profilaksis Pascavaksinasi

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Referensi

1. Kohl KS, Marcy SM, Blum M, Jones MC, Dagan R, Hansen J, Nalin D, Rothstein E, Brighton Collaboration Fever Working Group. Fever after immunization: current concepts and improved future scientific understanding. Clinical Infectious Diseases. 2004 Aug 1;39(3):389-94.
2. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit Kementerian Kesehatan Republik Indonesia.Petunjuk Teknis Kampanye Imunisasi Measles Rubella (MR). 2017.
3. Das RR, Panigrahi I, Naik SS. The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review. PLoS One. 2014 Sep 2;9(9):e106629.
4. Prymula R, Siegrist CA, Chlibek R, Zemlickova H, Vackova M, Smetana J, Lommel P, Kaliskova E, Borys D, Schuerman L. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. The Lancet. 2009 Oct 17;374(9698):1339-50.
5. Rose MA, Juergens C, Schmoele-Thoma B, Gruber WC, Baker S, Zielen S. An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine. BMC pediatrics. 2013 Dec;13(1):98.
6. Jackson LA, Peterson D, Dunn J, Hambidge SJ, Dunstan M, Starkovich P, Yu O, Benoit J, Dominguez-Islas CP, Carste B, Benson P. A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants. PLoS One. 2011 Jun 17;6(6):e20102.
7. Doedée AM, Boland GJ, Pennings JL, de Klerk A, Berbers GA, van der Klis FR, de Melker HE, van Loveren H, Janssen R. Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials. PloS one. 2014 Jun 4;9(6):e98175.
8. Gross PA, Levandowski RA, Russo C, Weksler M, Bonelli J, Dran S, Munk G, Deichmiller S, Hilsen R, Panush RF. Vaccine immune response and side effects with the use of acetaminophen with influenza vaccine. Clinical and diagnostic laboratory immunology. 1994 Mar 1;1(2):134-8.
9. Prymula R, Habib A, Francois N, Borys D, Schuerman L. Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol. Vaccine. 2013 Apr 12;31(16):2080-8.